ask="8.55"
ask_size="1000"
average_daily_volume="43919"
bid="5.55"
bid_size="400"
book_value="0.00"
change="+0.26"
change_from_200_day_moving_average="0.15"
change_from_50_day_moving_average="0.14"
change_from_52_week_high="-36.39"
change_From_52_week_low="1.62"
change_in_percent="+3.50%"
close="7.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="0.00"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="N/A"
high="8.27"
high_52_weeks="44.10"
last_trade_date="1/9/2017"
last_trade_price="7.71"
last_trade_size="100"
last_trade_time="3:59pm"
low="7.02"
low_52_weeks="6.09"
market_capitalization="76.52B"
moving_average_200_day="7.56"
moving_average_50_day="7.57"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.54"
pe_ratio="1.04"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.99%"
percent_change_from_50_day_moving_average="+1.82%"
percent_change_from_52_week_high="-82.52%"
percent_change_from_52_week_low="+26.60%"
previous_close="7.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9925000000"
short_ratio="0.00"
stock_exchange="NGM"
symbol="KALV"
volume="114213"
weeks_range_52="6.09 - 44.10"
